| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10175962 | Journal of Orthopaedic Science | 2007 | 6 Pages |
Abstract
Our results indicate that antiangiogenic therapy using endostatin has the potential to prevent postoperative progression of pulmonary metastasis from osteosarcoma. Although this therapeutic strategy cannot provide a cure for osteosarcoma, it should enable osteosarcoma patients to coexist with dormant pulmonary metastasis and lead to improvement of their prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Mitsunori Kaya, Takuro Wada, Satoshi Nagoya, Toshihiko Yamashita,